Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study.
Studies regarding mortality among patients with giant-cell-arteritis (GCA) have yielded conflicting results. Thus, in this large population-based study we aimed to examine whether GCA is associated with increased mortality, and if so, the effect of age at diagnosis and gender on the association. We utilized the medical database of Clalit-Health-Services for this retrospective cohort study. Follow-up was from January 1,2002 and continued until death or end of follow-up on September 1,2018. Incident GCA patients were compared with age-and-sex-matched controls. Estimated median survival-times were calculated using Kaplan-Meier method. Hazard-ratios for all-cause-mortality were obtained by the Cox proportional-hazard model, adjusted for sociodemographic variables and cardiovascular risk factors. The study included 7,294 GCA patients and 34,156 controls. The mean age at start of follow-up was 72.1±9.9 years with 69.2% females. Estimated median survival-time was 13.1 years (95% CI, 12.6-13.5 years) in GCA patients compared with 14.3 years (95% CI, 14.1-14.6) in controls (P-value < 0.001).The multivariate analysis demonstrated increased mortality risk in the first 2 years after diagnosis (HR 1.14; 95% CI 1.04-1.2) and >10 years after diagnosis (HR 1.14; 95% CI 1.02-1.3). The mortality-risk was higher in patients diagnosed ≤70 years of age (HR 1.5(95% CI 1.14-1.99) 0-2 years; HR 1.38(95% CI 1.1-1.7) >10 years). GCA patients have a minor decrease in long-term survival compared to age-andsex-matched controls. The seen difference is due to excess mortality in the first 2 years, and >10 years after diagnosis. Patients diagnosed ≤70 years of age are at greater risk.